Novartis Consumer Health, S.A.,
Nyon, Switzerland

In 1999, Aphios Corporation entered into an Agreement with Novartis Consumer Health to participate in a global research program to develop truly “green” and novel natural products for use in the food, nutraceutical and pharmaceutical industries.

Novartis is a world leader in healthcare with core businesses in pharmaceuticals, consumer health, generics, eye-care, and animal health. In 1998, the Group (including Agribusiness) achieved sales of CHF 31.7 billion and invested more than CHF 3.7 billion in R&D.  Headquartered in Basel, Switzerland, Novartis employs about 82,000 people and operates in over 140 countries around the world.  The Group recently announced plans to spin off its Crop Protection and Seeds sectors and to merge them with the agrochemicals business of AstraZeneca in the second half of 2000.  The company's U.S. headquarters are located in Summit, NJ.

Novartis Consumer Health is committed to becoming a world leader in the understanding and fulfillment of consumer self-care, health and medical nutrition needs.  The Company is dedicated to enhancing people’s overall health and well-being by offering superior brands for in-home diagnosis, treatment and prevention of medical conditions and ailments.

For more information on Novartis, visit them at www.novartis.com.

Home l Company | Product Pipeline | Patents | Press Releases | Purchase Products | Contact Aphios